Cloxacillin Sodium Intramammary Infusion
BRIEFING
Cloxacillin Sodium Intramammary Infusion. This proposal is based on the version of the monograph official as of May 1, 2020. It is proposed to omit this monograph because no drug products formulated as defined under Cloxacillin Sodium Intramammary Infusion are currently marketed in the United States.
(BIO4: J. Zhang)
Case ID—Sub-2310